VCIM
OPTN

Velan Capital Investment Management’s OptiNose OPTN Stock Holding History

Velan Capital Investment Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-143,107
Closed -$1.44M – 46
2024
Q3 		$1.44M Sell
143,107
-23,082
-14% -$337K 1.34% 12
2024
Q2 		$2.59M Sell
166,189
-33,890
-17% -$568K 1.49% 9
2024
Q1 		$4.38M Sell
200,079
-53,045
-21% -$1.18M 1.99% 10
2023
Q4 		$4.9M Buy
253,124
+13,333
+6% +$243K 2.86% 10
2023
Q3 		$4.42M Hold
239,791
– – 3.57% 9
2023
Q2 		$4.42M Buy
239,791
+6,667
+3% +$158K 4.11% 9
2023
Q1 		$6.75M Hold
233,124
– – 5.75% 7
2022
Q4 		$6.47M Buy
233,124
+88,019
+61% +$3.34M 5.72% 7
2022
Q3 		$7.97M Buy
145,105
+11,772
+9% +$646K 7.9% 5
2022
Q2 		$7.32M Hold
133,333
– – 7.43% 5
2022
Q1 		$4.94M Buy
+133,333
New +$4.76M 4.58% 9

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Velan Capital Investment Management's OPTN Position: Q4 2024 in Review

Velan Capital Investment Management sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 143,107 shares — an estimated $1.44M sold.

Velan Capital Investment Management first reported a position in OPTN in Q1 2022 and held it in 11 quarters. The position peaked at $7.97M in Q3 2022. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Velan Capital Investment Management reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Velan Capital Investment Management sold 143,107 OptiNose shares in Q4 2024, an estimated $1.44M.
  • Velan Capital Investment Management first reported a position in OptiNose in Q1 2022 and held it in 11 quarters.
  • Velan Capital Investment Management's OptiNose position peaked at $7.97M in Q3 2022.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Velan Capital Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.